These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2699207)

  • 1. Nutrient imbalances in depressive disorders. Possible brain mechanisms.
    Wurtman RJ; O'Rourke D; Wurtman JJ
    Ann N Y Acad Sci; 1989; 575():75-82; discussion 82-5. PubMed ID: 2699207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of seasonal depression with d-fenfluramine.
    O'Rourke D; Wurtman JJ; Wurtman RJ; Chebli R; Gleason R
    J Clin Psychiatry; 1989 Sep; 50(9):343-7. PubMed ID: 2670915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving.
    Docherty JP; Sack DA; Roffman M; Finch M; Komorowski JR
    J Psychiatr Pract; 2005 Sep; 11(5):302-14. PubMed ID: 16184071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. d-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of women with premenstrual depression.
    Brzezinski AA; Wurtman JJ; Wurtman RJ; Gleason R; Greenfield J; Nader T
    Obstet Gynecol; 1990 Aug; 76(2):296-301. PubMed ID: 2371034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbohydrate craving, mood changes, and obesity.
    Wurtman JJ
    J Clin Psychiatry; 1988 Aug; 49 Suppl():37-9. PubMed ID: 3045110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do the endocrine and subjective effects of d-fenfluramine predict response to selective serotonin reuptake inhibitors?
    Park SB; Williamson DJ; Cowen PJ
    Int Clin Psychopharmacol; 1995 Nov; 10(4):215-20. PubMed ID: 8748042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report of two double-blind randomized placebo-controlled pilot studies of a carbohydrate-rich nutrient mixture for treatment of seasonal affective disorder (SAD).
    Mischoulon D; Pedrelli P; Wurtman J; Vangel M; Wurtman R
    CNS Neurosci Ther; 2010; 16(1):13-24. PubMed ID: 19769596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of resistant depression with the citalopram-lithium combination. Methodology of a double-blind multicenter study and preliminary results].
    Souche A; Montaldi S; Uehlinger C; Kasas A; Reymond MJ; Reymond P; Baumann P; Dufour H
    Encephale; 1991; 17(3):213-9. PubMed ID: 1864255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. d-Fenfluramine selectively decreases carbohydrate but not protein intake in obese subjects.
    Wurtman JJ; Wurtman RJ
    Int J Obes; 1984; 8 Suppl 1():79-84. PubMed ID: 6534896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal serotonergic control of prolactin and cortisol secretion in patients with seasonal affective disorder.
    Coiro V; Volpi R; Marchesi C; De Ferri A; Davoli C; Caffarra P; Rossi G; Caffarri G; Davolio M; Chiodera P
    Psychoneuroendocrinology; 1993; 18(8):551-6. PubMed ID: 8127946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seasonal alteration in taste detection and recognition threshold in seasonal affective disorder: the proximate source of carbohydrate craving.
    Arbisi PA; Levine AS; Nerenberg J; Wolf J
    Psychiatry Res; 1996 Jan; 59(3):171-82. PubMed ID: 8930022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotoninergic drug-induced weight loss in carbohydrate craving obese patients.
    Toornvliet AC; Pijl H; Hopman E; Elte-de Wever BM; Meinders AE
    Int J Obes Relat Metab Disord; 1996 Oct; 20(10):917-20. PubMed ID: 8910095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of L-tryptophan on seasonal affective disorder.
    McGrath RE; Buckwald B; Resnick EV
    J Clin Psychiatry; 1990 Apr; 51(4):162-3. PubMed ID: 2182615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of d-fenfluramine in bulimia nervosa.
    Russell GF; Checkley SA; Feldman J; Eisler I
    Clin Neuropharmacol; 1988; 11 Suppl 1():S146-59. PubMed ID: 3052813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A placebo-controlled trial of d-fenfluramine in bulimia nervosa.
    Fahy TA; Eisler I; Russell GF
    Br J Psychiatry; 1993 May; 162():597-603. PubMed ID: 8149110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. d-fenfluramine treatment of binge eating disorder.
    Stunkard A; Berkowitz R; Tanrikut C; Reiss E; Young L
    Am J Psychiatry; 1996 Nov; 153(11):1455-9. PubMed ID: 8890680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response.
    Cleare AJ; Murray RM; O'Keane V
    Biol Psychiatry; 1998 Oct; 44(7):555-61. PubMed ID: 9787879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline characteristics of 10-day placebo washout responders in antidepressant trials.
    Rabkin JG; Stewart JW; McGrath PJ; Markowitz JS; Harrison W; Quitkin FM
    Psychiatry Res; 1987 May; 21(1):9-22. PubMed ID: 3299437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of bulimia with fenfluramine and desipramine.
    Blouin AG; Blouin JH; Perez EL; Bushnik T; Zuro C; Mulder E
    J Clin Psychopharmacol; 1988 Aug; 8(4):261-9. PubMed ID: 3062043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients.
    Abel KM; O'Keane V; Murray RM
    Br J Psychiatry; 1996 Jan; 168(1):57-60. PubMed ID: 8770429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.